Triton-MRL

Triton-MRL

Triton
Triton

Cultivation Process of Triton-MRL


Mycology Research Laboratories Ltd.´s Lentinula edodes (Shiitake), Ganoderma lucidum (Reishi) and Cordyceps sinensis are grown on a sterilised (autoclaved) substrate under ISO 22000:2018 standards in the EU.


This cultivation process ensures the powder complies with the EU regulation 1881/2006 for contamination of pesticides and heavy metals. The cultivation system is proprietary, allowing for standardised production of Lentinula edodes (Shiitake), Ganoderma lucidum (Reishi) and Cordyceps sinensis.

MRL mushrooms biomass offers a mixture of many co-operating and co-related healthful bioavailable ingredients prepared by nature itself – it is thus a truly pure natural product.

After cultivation the Lentinula edodes (Shiitake), Ganoderma lucidum (Reishi) and Cordyceps sinensis are then manufactured in the Netherlands into 500 mg tablets and in various powder forms to FSSC 22000 (Version 4.1) standards.

Veterinary products are manufactured under veterinary registration number (NL217476).

Moreover, all powder presentations are produced and manufactured in accordance with both EU and UK organic standards.

EU PT Bio 05 Logo
EU NL Bio 01 Logo
EU PT Bio 05 Logo
EU pt Bio 01 Logo
EU PT Bio 05 Logo
APCER 22000 IQNet Logos
UK Organic Logo
UK Organic Logo

Chemical and Biological Properties

Each Tablet of Triton MRL contains

Ganoderma lucidum - biomass powder 163.3 mg
Cordyceps sinensis - biomass powder 163.3 mg
Lentinula edodes - biomass powder 163.3 mg

Other ingredients

Microcrystalline Cellulose
Silica
Vegetable Magnesium Sterate

Triton MRL-Enzyme Activity Per 750 mg Tablet

Protein content 18.13 mg
Reducing sugars 13.6 mg
Protein-bound polysaccharide 73.5 mg
Peroxidase activity 47.2 mU
Laccase activity 421.5 mU
Glucoamylase / glucansase activity 2.2 U
Protease activity 34.4 mU